Pyridoxal 5'-phosphate is a slow tight binding inhibitor of E. coli pyridoxal kinase

PLoS One. 2012;7(7):e41680. doi: 10.1371/journal.pone.0041680. Epub 2012 Jul 25.

Abstract

Pyridoxal 5'-phosphate (PLP) is a cofactor for dozens of B(6) requiring enzymes. PLP reacts with apo-B(6) enzymes by forming an aldimine linkage with the ε-amino group of an active site lysine residue, thus yielding the catalytically active holo-B(6) enzyme. During protein turnover, the PLP is salvaged by first converting it to pyridoxal by a phosphatase and then back to PLP by pyridoxal kinase. Nonetheless, PLP poses a potential toxicity problem for the cell since its reactive 4'-aldehyde moiety forms covalent adducts with other compounds and non-B(6) proteins containing thiol or amino groups. The regulation of PLP homeostasis in the cell is thus an important, yet unresolved issue. In this report, using site-directed mutagenesis, kinetic, spectroscopic and chromatographic studies we show that pyridoxal kinase from E. coli forms a complex with the product PLP to form an inactive enzyme complex. Evidence is presented that, in the inhibited complex, PLP has formed an aldimine bond with an active site lysine residue during catalytic turnover. The rate of dissociation of PLP from the complex is very slow, being only partially released after a 2-hour incubation with PLP phosphatase. Interestingly, the inactive pyridoxal kinase•PLP complex can be partially reactivated by transferring the tightly bound PLP to an apo-B(6) enzyme. These results open new perspectives on the mechanism of regulation and role of pyridoxal kinase in the Escherichia coli cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Diphosphate / metabolism
  • Adenosine Triphosphate / metabolism
  • Biocatalysis
  • Catalytic Domain
  • Enzyme Activation
  • Enzyme Inhibitors / metabolism*
  • Enzyme Inhibitors / pharmacology*
  • Escherichia coli / enzymology*
  • Humans
  • Kinetics
  • Ligands
  • Models, Molecular
  • Protein Binding
  • Pyridoxal Kinase / antagonists & inhibitors*
  • Pyridoxal Kinase / chemistry
  • Pyridoxal Kinase / metabolism*
  • Pyridoxal Phosphate / metabolism*
  • Pyridoxal Phosphate / pharmacology*

Substances

  • Enzyme Inhibitors
  • Ligands
  • Pyridoxal Phosphate
  • Adenosine Diphosphate
  • Adenosine Triphosphate
  • Pyridoxal Kinase

Grants and funding

The work was supported by AD Williams Fund (VCU) and the Jeffress Research Grant Award to MKS; and by Ministero dell’Università e della Ricerca and a grant from Istituto Pasteur-Fondazione Cenci Bolognetti to MLDS and RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.